Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
CYD32
Phase 3 mab completed
Quick answer
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus for Dengue Fever is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Dengue Fever
- Phase
- Phase 3
- Modality
- mab
- Status
- completed